STRAP as a New Therapeutic Target for Poor Prognosis of Pancreatic Ductal Adenocarcinoma Patients Mainly Caused by TP53 Mutation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

STRAP as a New Therapeutic Target for Poor Prognosis of Pancreatic Ductal Adenocarcinoma Patients Mainly Caused by TP53 Mutation

Published:2020-09-29 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Hu Shanshan,Chen Xiao,Xu Xiangxiang,Zheng Chenlei,Huang Wenqian,Zhou Yi,Akuetteh Percy David Papa,Yang Hongbao,Shi Keqing,Chen Bicheng,Zhang Qiyu

Funder

National Natural Science Foundation of China

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference56 articles.

1. Epidemiology of pancreatic cancer.;Ilic;World J Gastroenterol.,2016

2. Cancer statistics, 2019.;Siegel;CA Cancer J Clin.,2019

3. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.;Rahib;Cancer Res.,2014

4. Pancreatic cancer surgery in the new millennium: better prediction of outcome.;Hartwig;Ann Surgery.,2011

5. Pancreatic cancer.;Vincent;Lancet (Lond Engl).,2011

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into gemcitabine resistance in pancreatic cancer: association with metabolic reprogramming and TP53 pathogenicity in patient derived xenografts;Journal of Translational Medicine;2024-08-05

2. Post‐operative mortality and recurrence patterns in pancreatic cancer according to KRAS mutation and CDKN2A, p53, and SMAD4 expression;The Journal of Pathology: Clinical Research;2023-06-08

3. Squalene epoxidase promotes hepatocellular carcinoma development by activating STRAP transcription and TGF‐β/SMAD signalling;British Journal of Pharmacology;2023-01-24

4. Inhibition of Clusterin Represses Proliferation by Inducing Cellular Senescence in Pancreatic Cancer;Annals of Surgical Oncology;2022-04-10

5. An immune‐related seven‐lncRNA signature for head and neck squamous cell carcinoma;Cancer Medicine;2021-03-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3